HA
BMY.RT

H2O AM’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

H2O AM’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$89K Hold
55,431
– – 0.22% 71
2020
Q3 		$124K Hold
55,431
– – 0.2% 72
2020
Q2 		$199K Hold
55,431
– – 0.21% 83
2020
Q1 		$209K Buy
55,431
+7,914
+17% +$26.1K 0.17% 113
2019
Q4 		$143K Buy
+47,517
New +$124K 0.03% 83

Other funds holding BMY.RT

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

H2O AM's BMY.RT Position: Q4 2020 in Review

H2O AM held its Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) position steady in Q4 2020 at 55,431 shares worth $89K. The position accounts for 0.22% of the portfolio, ranked #71.

H2O AM first reported a position in BMY.RT in Q4 2019 and has held it in 5 quarters since. The position peaked at $209K in Q1 2020. 546 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2020.

  • H2O AM held 55,431 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $89K as of Q4 2020.
  • H2O AM left its Bristol-Myers Squibb Company Contingent Value Rights share count unchanged in Q4 2020.
  • Bristol-Myers Squibb Company Contingent Value Rights made up 0.22% of H2O AM's portfolio in Q4 2020, its #71 holding.
  • H2O AM first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and has held it in 5 quarters since.
  • H2O AM's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $209K in Q1 2020.
  • 546 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2020.

Based on H2O AM's 13F filing for Q4 2020, filed 12 Feb 2021.